Home » Topics » Regulatory

Regulatory
RSS

China approves Epidaza for peripheral T-cell lymphoma

Jan. 13, 2015

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Dec. 30, 2014

Takecab approved for the treatment of acid-related diseases in Japan

Dec. 30, 2014

FDA approves Namzaric for Alzheimer's disease

Dec. 29, 2014

Liraglutide approved in U.S. for weight loss

Dec. 24, 2014

European marketing approval granted to Clinuvel's Scenesse

Dec. 23, 2014

FDA approves AbbVie's Viekira Pak for chronic genotype 1 HCV infection

Dec. 23, 2014

U.S. approval for Cubist's ceftolozane/tazobactam for cUTI and cIAI

Dec. 22, 2014

Olaparib receives E.U. approval for BRCA-mutated ovarian cancer

Dec. 19, 2014

FDA approves ear drop formulation of finafloxacin for acute otitis externa

Dec. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...